MA43184A - Composition liposomale et son procédé de production - Google Patents

Composition liposomale et son procédé de production

Info

Publication number
MA43184A
MA43184A MA043184A MA43184A MA43184A MA 43184 A MA43184 A MA 43184A MA 043184 A MA043184 A MA 043184A MA 43184 A MA43184 A MA 43184A MA 43184 A MA43184 A MA 43184A
Authority
MA
Morocco
Prior art keywords
production process
liposomal composition
liposomal
composition
production
Prior art date
Application number
MA043184A
Other languages
English (en)
Inventor
Hiroyuki Kitaoka
Mikinaga Mori
Kentaro Numajiri
Takahiro Sekiguchi
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of MA43184A publication Critical patent/MA43184A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA043184A 2015-11-02 2016-11-01 Composition liposomale et son procédé de production MA43184A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015215767 2015-11-02

Publications (1)

Publication Number Publication Date
MA43184A true MA43184A (fr) 2021-04-14

Family

ID=58662894

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043184A MA43184A (fr) 2015-11-02 2016-11-01 Composition liposomale et son procédé de production

Country Status (5)

Country Link
US (2) US20180243215A1 (fr)
EP (1) EP3372223B1 (fr)
JP (2) JP6564873B2 (fr)
MA (1) MA43184A (fr)
WO (1) WO2017078009A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2836772T3 (es) 2014-04-30 2021-06-28 Fujifilm Corp Composición liposomal y método para producirla
JP2021181426A (ja) 2020-04-03 2021-11-25 富士フイルム株式会社 抗腫瘍剤

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2566559A (en) * 1951-09-04 Preparation of agetals
JP2931981B2 (ja) * 1988-03-04 1999-08-09 武田薬品工業株式会社 リポソーム製剤およびその製造法
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
IS1685B (is) * 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5993850A (en) * 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
DE69632859T2 (de) * 1995-04-18 2005-07-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Verfahren zur Arzneistoffbehandlung von Liposomen Zusammensetzung
DE19813773A1 (de) 1998-03-27 1999-09-30 Clemens Unger Verfahren zur Herstellung von liposomalen Wirkstoffformulierungen
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
JP2000302685A (ja) * 1999-02-18 2000-10-31 Sankyo Co Ltd 抗腫瘍薬含有リポソーム製剤
US6727475B2 (en) * 2001-07-27 2004-04-27 Eastman Kodak Company Heating control system which minimizes AC power line voltage fluctuations
WO2003083443A2 (fr) * 2002-03-29 2003-10-09 University Of Florida Criblage a base de lipides de medicaments candidats, destine a l'identification de composes actifs
EP1608337A2 (fr) * 2003-04-02 2005-12-28 Celator Technologies Inc. Compositions combinees de camptothecines et de fluoropyrimidines
WO2005021012A1 (fr) * 2003-08-29 2005-03-10 Terumo Kabushiki Kaisha Vecteur de medicament contenant de la gemcitabine
EP1744764B1 (fr) * 2004-04-22 2012-05-30 Celator Pharmaceuticals, Inc. Formulations a vecteur intracellulaires pour anthracycliniques et analogues cytidiniques
KR101462819B1 (ko) * 2004-05-03 2014-11-21 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
JP4758915B2 (ja) * 2004-08-06 2011-08-31 バイオスペクトラム，インコーポレイテッド 多重層リポソームおよびその製造方法
EP1796689A4 (fr) * 2004-09-20 2009-01-14 British Columbia Cancer Agency Gemcitabine libre ou encapsulee dans des liposomes seule ou en association avec de l'idarubicine libre ou encapsulee dans des liposomes
JP5110880B2 (ja) * 2004-11-18 2012-12-26 テルモ株式会社 医薬組成物、製剤および組み合わせ製剤
EP1674081A1 (fr) * 2004-12-23 2006-06-28 KTB Tumorforschungsgesellschaft mbH Préparation de nano-particules à bases lipides en utilisant une centrifuge duale et asymétrique
US20100209364A1 (en) * 2007-07-20 2010-08-19 Rohto Pharmaceutical Co., Ltd. Emulsified Composition
WO2009059449A1 (fr) * 2007-11-05 2009-05-14 Celsion Corporation Nouveaux liposomes thermosensibles contenant des agents thérapeutiques
US8079820B2 (en) * 2008-12-18 2011-12-20 General Electric Company Blade module, a modular rotor blade and a method for assembling a modular rotor blade
CN102369008B (zh) * 2009-03-30 2014-10-29 卫材R&D管理有限公司 脂质体组合物
US8215869B2 (en) * 2009-07-27 2012-07-10 Terratech Consulting Ltd. Reinforced soil arch
CN102858958A (zh) * 2010-02-03 2013-01-02 日本国立癌症研究中心 诱导肝干细胞及其制造方法、以及该细胞的用途
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
JP2015507019A (ja) * 2012-02-17 2015-03-05 セルシオン コーポレイション 感熱性ナノ粒子製剤およびその製造方法
US20140029493A1 (en) * 2012-07-26 2014-01-30 Sierra Wireless, Inc. Wireless Communication Interworking Function
KR20140120218A (ko) * 2013-04-02 2014-10-13 삼성전자주식회사 혈관신생 유도 물질 전달용 조성물, 및 이를 이용하여 제작된 인공 조직
WO2015166987A1 (fr) * 2014-04-30 2015-11-05 富士フイルム株式会社 Composition liposomale et procédé de production associé
JP6263609B2 (ja) * 2014-04-30 2018-01-17 富士フイルム株式会社 リポソーム組成物及びその製造方法
ES2836772T3 (es) * 2014-04-30 2021-06-28 Fujifilm Corp Composición liposomal y método para producirla
DK3138556T3 (da) * 2014-04-30 2022-04-11 Fujifilm Corp Fremgangsmåde til fremstilling af liposomer
JP6316182B2 (ja) * 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置

Also Published As

Publication number Publication date
EP3372223A1 (fr) 2018-09-12
US20210128471A1 (en) 2021-05-06
JP2019178181A (ja) 2019-10-17
EP3372223A4 (fr) 2018-09-12
WO2017078009A1 (fr) 2017-05-11
JP6564873B2 (ja) 2019-08-21
US20180243215A1 (en) 2018-08-30
JPWO2017078009A1 (ja) 2018-08-09
JP6705933B2 (ja) 2020-06-03
EP3372223B1 (fr) 2024-04-17

Similar Documents

Publication Publication Date Title
MA42836A (fr) Composition d'élastomère thermoplastique et son procédé de production
MA41861A (fr) Composition d'élastomère thermoplastique et son procédé de production
SG10201601042PA (en) Production of ester mixtures
DK3341479T3 (da) LNA-G-Proces
GB201516516D0 (en) Process of manufacture
SG10201911807PA (en) Antifouling Composition and Process for Production Thereof
MA48798A (fr) Procédé de production d'ozanimod
MA41941A (fr) Procédé de purification de protéines
BR112017009040A2 (pt) produção de um material de espinélio
FI20155621A (fi) Menetelmä ja tuote
FI20155429A (fi) Hiova tuote ja menetelmä sen valmistamiseksi
FI20155425A (fi) Prosessi nanofibrilliselluloosan hydrogeelin tuottamiseksi
SI3138555T1 (sl) Liposomski sestavek in proizvodni postopek zanj
MA46454A (fr) Procédé multi-protéase
FR3018631B1 (fr) Caloduc et son procede de fabrication
PL3386929T3 (pl) Sposób i instalacja do otrzymywania barwnego oszklenia
MA43184A (fr) Composition liposomale et son procédé de production
PL3271325T3 (pl) Sposób wytwarzania (S)-metolachloru
CL2015001349A1 (es) Proceso de producción de perlas libres de abalón
BR112017025694A2 (pt) produção biotecnológica de ésteres de vetiveril
FI20155729A (fi) Menetelmä ja tuote
MA41148A (fr) Procédé de fabrication d'idalopirdine
GB201700973D0 (en) Process of manufacture
DE112015000840A5 (de) Textiler Verbundwerkstoff und Verfahren zu seiner Herstellung
MA50370A (fr) Procédé de sécurisation